Clinical characteristics and management of chronic spontaneous urticaria in patients refractory to H1-Antihistamines in Asia, Middle-East and Africa: Results from the AWARE-AMAC study
暂无分享,去创建一个
N. Agmon-Levin | C. Chu | R. Arnaout | N. Atakan | K. Kulthanan | Kathryn Cooke | S. Crowe | E. Dekker | F. Zaitoun | A. Al Hammadi | S. Kannenberg | Assem Farag | Asmara Mubarak | Sigrid Malfait
[1] M. Labrador-Horrillo,et al. Differences in chronic spontaneous urticaria between Europe and Central/South America: results of the multi-center real world AWARE study , 2018, The World Allergy Organization journal.
[2] F. Bérard,et al. Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: Analyses from ASSURE‐CSU , 2018, Allergy.
[3] A. Giménez-Arnau,et al. Clinical Features of Chronic Spontaneous Urticaria that Predict Disease Prognosis and Refractoriness to Standard Treatment. , 2018, Acta dermato-venereologica.
[4] T. Zuberbier,et al. The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria , 2018, Allergy.
[5] M. Hide,et al. Impact of chronic urticaria on quality of life and work in Japan: Results of a real‐world study , 2018, The Journal of dermatology.
[6] S. Youn,et al. Epidemiology and comorbidities of patients with chronic urticaria in Korea: A nationwide population‐based study , 2018, The Journal of dermatology.
[7] Ji-Hye Kim,et al. Disease-specific impairment of the quality of life in adult patients with chronic spontaneous urticaria , 2016, The Korean journal of internal medicine.
[8] C. Chu,et al. Epidemiology and comorbidities of patients with chronic urticaria in Taiwan: A nationwide population-based study. , 2017, Journal of dermatological science.
[9] F. Bérard,et al. The burden of chronic spontaneous urticaria is substantial: Real‐world evidence from ASSURE‐CSU , 2017, Allergy.
[10] D. Simancas-Racines,et al. Knowledge and management of chronic spontaneous urticaria in Latin America: a cross-sectional study in Ecuador , 2017, The World Allergy Organization journal.
[11] A. Knulst,et al. Effectiveness and safety of antihistamines up to fourfold or higher in treatment of chronic spontaneous urticaria , 2017, Clinical and Translational Allergy.
[12] M. Rimoldi,et al. State of the art of chronic spontaneous urticaria in Italy: a multicentre survey to evaluate physicians’ and patients’ perspectives , 2016, BMJ Open.
[13] C. Chu,et al. Unmet medical needs for chronic spontaneous urticaria patients: highlighting the real‐life clinical practice in Taiwan , 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.
[14] A. Knulst,et al. Work Productivity and Activity Impairment Among Chronic Spontaneous/Idiopathic Urticaria Patients: ResultsFrom The First International Burden of Illness Study (Assure-Csu). , 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[15] J. Vietri,et al. Effect of chronic urticaria on US patients: analysis of the National Health and Wellness Survey. , 2015, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[16] T. Casale,et al. Similar Efficacy with Omalizumab in Chronic Idiopathic/Spontaneous Urticaria Despite Different Background Therapy. , 2015, The journal of allergy and clinical immunology. In practice.
[17] T. Zuberbier,et al. The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. , 2014, Allergy.
[18] P. Kuna,et al. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. , 2013, The Journal of allergy and clinical immunology.
[19] T. Casale,et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. , 2013, The New England journal of medicine.
[20] T. Zuberbier,et al. Management of chronic spontaneous urticaria in real life – in accordance with the guidelines? A cross‐sectional physician‐based survey study , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.
[21] T. Zuberbier,et al. Diagnosis and Treatment of Urticaria and Angioedema: A Worldwide Perspective , 2012, The World Allergy Organization journal.
[22] A. Barbosa,et al. Chronic idiopathic urticaria and anxiety symptoms , 2011, Journal of health psychology.
[23] J. Bousquet,et al. Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report 1 , 2011, Allergy.
[24] T. Zuberbier,et al. Chronic urticaria: a patient survey on quality‐of‐life, treatment usage and doctor–patient relation , 2009, Allergy.
[25] H. Schünemann,et al. EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria , 2006, Allergy.
[26] M. Sticherling,et al. Chronic urticaria – which clinical parameters are pathogenetically relevant? A retrospective investigation of 339 patients , 2007, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[27] T. Zuberbier,et al. EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria , 2006, Allergy.